Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ekso Bionics Holdings (EKSO) Accumulated Depreciation & Amortization (2016 - 2025)

Ekso Bionics Holdings has reported Accumulated Depreciation & Amortization over the past 13 years, most recently at $3.8 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 12.36% to $3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 million, a 12.36% increase, with the full-year FY2025 number at $3.8 million, up 12.36% from a year prior.
  • Accumulated Depreciation & Amortization reached $3.8 million in Q4 2025 per EKSO's latest filing, up from $3.3 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $3.8 million in Q4 2025, with the low at $887000.0 in Q4 2022.
  • The 5-year median for Accumulated Depreciation & Amortization is $3.2 million (2023), against an average of $2.4 million.
  • Peak YoY movement for Accumulated Depreciation & Amortization: decreased 13.29% in 2022, then skyrocketed 255.81% in 2023.
  • Tracing EKSO's Accumulated Depreciation & Amortization over 5 years: stood at $1.0 million in 2021, then decreased by 13.29% to $887000.0 in 2022, then skyrocketed by 255.81% to $3.2 million in 2023, then rose by 5.86% to $3.3 million in 2024, then increased by 12.36% to $3.8 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $3.8 million, $3.3 million, and $3.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.